ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610457 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610457; 2) Community: the network communities that were significantly associated with the response to NSC 610457; 3) Molecule: the relationships between components within communities and NSC 610457; 4) MDR: the compounds that were significantly associated with the NSC 610457.

NSC Compound Enrichment Correlation
NSC 737518 Indenoisoquinoline derivative 0.000272379738694984 0.8278759
NSC 83142 Daunorubicin hydrochloride 0.000294004970380715 0.57885006
NSC 606869 Clofarabine 0.000316069426108867 0.44509766
NSC 295500 Camptothecin Derivative 0.000497857311992526 0.81021635
NSC 619031 Analog of CC-1065 0.000659507126432943 0.77935621
NSC 717859 Null 0.000659507126432943 -0.050813483
NSC 726332 6-[3-((2,2-Dimethoxyethylamino)-1-propyl)]-5,6-dihydro-2,3- dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c] isoquinoline 0.000659507126432943 0.60454978
NSC 733883 6-(3-Chloropropyl)-5,6-dihydro-7-methoxy-3-nitro-5,11-dioxo- 11H-indeno[1,2-c]isoquinoline 0.000659507126432943 0.51836342
NSC 76919 2-Pyridinecarboxylic acid, 5-amino-6-(7-amino-1,2,3,4,5,8-hexahydro- 5,8-dioxo-2-quinolinyl)-4-(2-hydroxy- 3,4-dimethoxyphenyl)-3-methyl- 0.000659507126432943 0.71622297
NSC 176323 Camptothecin Derivative 0.000706163530262832 0.88457576
Total:58  Current:2    [First] [Prev] [Next] [Last]